Maryland biopharmaceutical firm NextCure raises $86.25M in IPO

NextCure Inc., a Beltsville biopharmaceutical company working on medicines for cancer and other diseases, raised $86.25 million in its initial public offering, the company announced Monday.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *